Why older adults with insomnia are more vulnerable to depression

Most of us have had a few nights of tossing and turning, staring at the ceiling, wondering why sleep won't come. But for millions of older adults, insomnia is a nightly battle. And new research suggests that sleeplessness may do more than make us groggy and irritable. It may actually rewire how our brains respond to stress and inflammation, leaving us more vulnerable to depression.

That's the conclusion of a major study published in JAMA Psychiatry by Dr. Michael Irwin and colleagues at the University of California, Los Angeles (UCLA). Their team, based at the Cousins Center for Psychoneuroimmunology and the Jane and Terry Semel Institute for Neuroscience and Human Behavior explored a question that had puzzled scientists for years: could insomnia make the brain more sensitive to inflammation, thereby increasing the risk of depression in later life?

As we age, our immune systems undergo subtle but important changes. Low-grade, chronic inflammation becomes more common, a phenomenon researchers have nicknamed "inflammaging." At the same time, many older adults struggle with insomnia, which affects both mental and physical health.

Previous studies had hinted that inflammation might play a role in depression. When people get sick or even receive certain immune treatments, many develop depressive symptoms, fatigue, sadness, social withdrawal. Yet it wasn't clear whether people with insomnia were more biologically primed to react this way.

Dr. Irwin, a pioneer in the field of mind–body medicine, suspected that poor sleep might set the stage for an exaggerated emotional response to inflammation. We know sleep deprivation affects the immune system but this study tested whether that biological stress translates into mood changes, particularly in older adults.

To investigate, the UCLA team conducted a randomized clinical trial from 2017 to 2022, involving 160 adults aged 60 and older. None had depression at the start of the study, but about a third met criteria for insomnia disorder.

Participants were randomly assigned to receive either a placebo (a harmless saline solution) or a tiny, safe dose of endotoxin, a bacterial substance that temporarily activates the immune system, mimicking an infection. This "inflammatory challenge" is a well-established method for studying how the body and brain respond to inflammation.

Then came the waiting, and the watching. Over the next nine hours, the team carefully monitored participants' mood, inflammatory markers, and physical symptoms.

When inflammation kicked in, everyone felt a little worse, more tired, achy, and down. But for those with insomnia, the emotional impact was far more severe.

Compared to the well-rested control group, older adults with insomnia experienced a threefold greater increase in depressed mood after the endotoxin injection. The sadness and emotional slump also lasted longer, lingering for hours even as inflammation subsided.

Interestingly, both groups showed similar biological responses: levels of inflammatory molecules like interleukin-6 (IL-6) and tumor necrosis factor (TNF) rose equally. But only the insomnia group showed a strong link between these immune changes and their mood. In other words, their brains seemed more sensitive to the chemical signals of inflammation.

This finding suggests that, in addition to the inflammation itself, how the brain reacts to it really matters.

The team offered several possible explanations as how why poor sleep magnifies depression risk. Chronic sleep loss, they noted, may disrupt the blood–brain barrier, allowing immune molecules to enter the brain more easily. Once there, these molecules can activate microglia, the brain's immune cells, which can trigger neural inflammation and interfere with mood-regulating circuits.

Sleep problems may also throw off circadian rhythms, the body's internal clock, which helps coordinate immune and hormonal activity. When that rhythm is disrupted, the balance between rest, repair, and emotional regulation can unravel.

Whatever the mechanism, the outcome is clear: a sleepless brain appears to be an "amplifier" for stress and inflammation, making depression more likely when the body is under strain.

One of the most interesting aspects of this study is that it moves beyond correlation to demonstrate causation, at least under experimental conditions. Previous research had shown that people with insomnia are more likely to develop depression, but this trial shows that inflammation can actually trigger depressive symptoms, especially in those who sleep poorly.

The findings also echo a growing body of research linking the immune system to mental health. Scientists are increasingly viewing depression not just as a psychological condition, but as a whole-body disorder, one influenced by immune activity, metabolism, and even the gut microbiome.

Indeed, the study highlights that older adults with insomnia are a high-risk group for developing depression, particularly during periods of illness, injury, or inflammation. Even mild infections, like the flu or a lingering cold, might trigger depressive symptoms in vulnerable individuals.

Also, it calls for proactive depression monitoring in older adults with chronic sleep problems. Regular screening, especially during hospital stays or inflammatory illnesses, could catch mood changes early before they spiral into major depression.

Finally, the results suggest that treating insomnia might be one of the most effective, and underused, ways to prevent late-life depression. Behavioral therapies for insomnia, such as Cognitive Behavioral Therapy for Insomnia (CBT-I), have already been shown to reduce depression risk in older adults. Combining these with anti-inflammatory or lifestyle interventions (like mindfulness, tai chi, or moderate exercise) could provide a powerful two-pronged approach.

The UCLA team already has a follow-up study underway to see whether these "depression sensitivity" responses to inflammation can predict who will go on to develop clinical depression over time. If so, this could open the door to a new era of personalized mental health care, where biological markers like inflammation, combined with behavioral factors like sleep, help identify those at greatest risk and guide targeted prevention. It also challenges us to think differently about aging. Depression isn't an inevitable part of getting older, but it does have biological roots that can be understood, and, hopefully, mitigated.

So, if you're an older adult struggling with insomnia, this study offers an important message: your restless nights matter, not just for your energy levels, but for your emotional well-being.

Taking steps to improve sleep hygiene, seeking treatment for insomnia, and paying attention to your mood during times of illness or stress can all make a difference. And for clinicians, it's a reminder that sleep and inflammation aren't side notes in mental health, they're central players.

As Dr. Irwin and his colleagues put it, understanding how the immune system and the mind interact could help us “prevent depression before it takes hold”, a goal that feels more urgent than ever as our population ages.

If you want to learn more, read the original article titled "Inflammatory Exposure and Depression in Older Adults With Insomnia A Randomized Clinical Control Trial" on JAMA Psychiatry at http://dx.doi.org/10.1001/jamapsychiatry.2025.1327.